Treating hematologic malignancies with engineered T cells
This article explores new targets in solid tumors for treating patients with hematologic malignancies.
Stay updated with breaking news from Hematologic Malignancies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article explores new targets in solid tumors for treating patients with hematologic malignancies.
/PRNewswire/ -- Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present a wide-ranging scope of new...
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update - Data from T cell Engager Portfolio for Hematologic Malignancies, Including First... | November 3, 2022
WALTHAM, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
More than 900 medical facilities have been destroyed or damaged, says Ruslan Zelinskyi, MS, from the Spizhenko Clinic in Ukraine.